Search

everythinglearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Clobetasol is more effective than metformin for treating localized alopecia areata.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Baricitinib may effectively treat lichen planopilaris.

Tofacitinib might be used to treat hair loss.

Tridax procumbens may help treat diabetes.

Agomelatine might help reduce hair loss caused by valproate.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

Latanoprost effectively and safely promotes eyelash growth.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Latanoprost, a glaucoma treatment, was found ineffective in treating hair loss in eyebrows and eyelashes.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Combining capislow with laser is more effective for reducing unwanted hair, but the effect is temporary.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.